These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Homocysteine: the Rubik's cube of cardiovascular risk factors. Milani RV; Lavie CJ Mayo Clin Proc; 2008 Nov; 83(11):1200-2. PubMed ID: 18990317 [No Abstract] [Full Text] [Related]
4. Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice. Wilson KM; McCaw RB; Leo L; Arning E; Lhoták S; Bottiglieri T; Austin RC; Lentz SR Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):233-40. PubMed ID: 17082485 [TBL] [Abstract][Full Text] [Related]
5. Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats. Sharma M; Rai SK; Tiwari M; Chandra R Eur J Pharmacol; 2007 Nov; 574(1):49-60. PubMed ID: 17706635 [TBL] [Abstract][Full Text] [Related]
6. The new kid on the block: the unfolded protein response in the pathogenesis of atherosclerosis. Vasa-Nicotera M Cell Death Differ; 2004 Jul; 11 Suppl 1():S10-1. PubMed ID: 15243579 [No Abstract] [Full Text] [Related]
7. [Cellular and molecular mechanism of cardiovascular disease resulting from hyperhomocysteinemia]. Gao L; Tang CS Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):335-8. PubMed ID: 12650071 [No Abstract] [Full Text] [Related]
8. [Characteristics of hyperhomocysteinemia in dialysis patients]. Lovcić V; Kes P; Reiner Z Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568 [TBL] [Abstract][Full Text] [Related]
9. Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients. Tayama J; Munakata M; Yoshinaga K; Toyota T Hypertens Res; 2006 Jun; 29(6):403-9. PubMed ID: 16940702 [TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia and atherosclerosis. Yang F; Tan HM; Wang H Sheng Li Xue Bao; 2005 Apr; 57(2):103-14. PubMed ID: 15830093 [TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocysteinemia. A new coronary risk factor]. Zacarías-Castillo R; Hernández-Rebollar AE; Zajarias-Rabchinskey A; González-Bárcena D Gac Med Mex; 2001; 137(4):335-45. PubMed ID: 11519357 [TBL] [Abstract][Full Text] [Related]
12. [Role of methylation in atherosclerosis accelerated by hyperhomocysteinemia]. Wang N; Feng J; Wang X Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):267-71. PubMed ID: 23189620 [No Abstract] [Full Text] [Related]
13. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor]. Caramia G; Belardinelli R Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847 [TBL] [Abstract][Full Text] [Related]
14. [Advances in studies on the protein homocysteinylation]. Li J; Feng J; Wang X Sheng Li Ke Xue Jin Zhan; 2011 Aug; 42(4):291-5. PubMed ID: 22066422 [No Abstract] [Full Text] [Related]
15. [Hyperhomocysteinemia--a risk factor in atherosclerosis]. Marković N; Stefanović V Srp Arh Celok Lek; 1999; 127(9-10):326-32. PubMed ID: 10649903 [No Abstract] [Full Text] [Related]
16. Immunoregulatory effects of homocysteine on cardiovascular diseases. Dai J; Wang X Sheng Li Xue Bao; 2007 Oct; 59(5):585-92. PubMed ID: 17940698 [TBL] [Abstract][Full Text] [Related]
17. Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin. Perna AF; Castaldo P; Ingrosso D; De Santo NG J Nephrol; 1999; 12(4):230-40. PubMed ID: 10493566 [TBL] [Abstract][Full Text] [Related]
19. Are we losing homocysteine as a cardiovascular risk factor? Bunout D; Hirsch S Nutrition; 2005 Oct; 21(10):1068-9. PubMed ID: 16157246 [No Abstract] [Full Text] [Related]
20. Methionine-induced hyperhomocysteinemia modulates lipoprotein profile and oxidative stress but not progression of atherosclerosis in aged apolipoprotein E knockout mice. Song Y; Cho M; Cho C; Rosenfeld ME J Med Food; 2009 Feb; 12(1):137-44. PubMed ID: 19298207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]